AirSculpt Technologies (NASDAQ:AIRS – Get Free Report) issued its earnings results on Friday. The company reported ($0.08) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.03) by ($0.05), FiscalAI reports. AirSculpt Technologies had a negative net margin of 7.79% and a negative return on equity of 5.83%. The company had revenue of $31.94 million during the quarter, compared to analyst estimates of $34.33 million.
Here are the key takeaways from AirSculpt Technologies’ conference call:
- Negative Sentiment: Third-quarter results fell short: revenue declined 8.7% year over year, same-center case volume fell 9.6%, and adjusted EBITDA dropped to about $0.4 million from $3 million. Management attributed the weakness to lower marketing productivity and operational challenges at several centers.
- Negative Sentiment: Google’s AI Overviews reduced traffic reaching AirSculpt’s website, contributing to 16% fewer leads and a 26% higher cost per lead; customer acquisition cost rose to about $3,800 per case from $3,100. Management said it is working to improve AI-search visibility and expand local marketing, but noted those efforts may take time to affect revenue.
- Negative Sentiment: AirSculpt cut its 2026 outlook, now expecting revenue of $144 million–$146 million versus $151 million–$157 million previously, and adjusted EBITDA of $9 million–$10 million versus $12 million–$14 million. The revised forecast assumes third-quarter trends continue through Q4.
- Positive Sentiment: GLP-1-related procedures reached 250 in the quarter, nearly 10% of total cases, and are now offered in almost all centers. Management sees a potential $100 million-plus long-term revenue opportunity, while acknowledging that these newer services require tailored marketing and patient education.
- Positive Sentiment: The company refinanced its debt with a $44 million facility maturing in 2031, extending its maturity and providing more covenant and payment flexibility; quarter-end liquidity was about $20 million. The new loan carries an interest rate roughly 300 basis points above the prior facility.
AirSculpt Technologies Trading Down 62.9%
AirSculpt Technologies stock traded down $0.91 during trading hours on Friday, reaching $0.53. 11,073,870 shares of the company were exchanged, compared to its average volume of 828,261. The stock has a 50-day moving average of $1.87 and a 200 day moving average of $3.08. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.32. AirSculpt Technologies has a 12 month low of $0.52 and a 12 month high of $8.09.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on AIRS shares. Wall Street Zen cut AirSculpt Technologies from a “buy” rating to a “hold” rating in a report on Saturday, August 15th. Weiss Ratings reissued a “sell (d-)” rating on shares of AirSculpt Technologies in a research note on Monday, September 28th. Finally, Lake Street Capital initiated coverage on AirSculpt Technologies in a research report on Thursday, October 29th. They issued a “buy” rating and a $3.00 price target for the company. One equities research analyst has rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $3.75.
Read Our Latest Report on AIRS
AirSculpt Technologies News Summary
Here are the key news stories impacting AirSculpt Technologies this week:
- Negative Sentiment: For the quarter ended September 30, revenue fell 8.7% year over year to $31.9 million, below the $34.3 million analyst estimate. AirSculpt also reported a loss of $0.08 per share, worse than the expected $0.03 loss. AirSculpt Q3 results
- Negative Sentiment: The company cut its 2026 revenue guidance to $144 million–$146 million, below the roughly $151 million consensus forecast. The reduced outlook reinforces concerns about near-term growth. AirSculpt cuts 2026 guidance
AirSculpt Technologies Company Profile
AirSculpt Technologies, Inc operates a medical aesthetics business focused on body-contouring and cosmetic procedures. Through its AirSculpt brand, the company provides minimally invasive liposuction and fat-transfer treatments designed to remove unwanted fat and reshape areas of the body.
Its services also include procedures such as skin tightening and other elective aesthetic treatments, with offerings varying by location and patient needs. AirSculpt markets its procedures directly to consumers and provides consultations, treatment planning and follow-up care through its network of company-operated centers.
The company was founded in 2015 by plastic surgeon Dr.
Read More
- Five stocks we like better than AirSculpt Technologies
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for AirSculpt Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AirSculpt Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
